��ժҪ��Ϣ

[an error occurred while processing this directive]

��Ƥ��Բ�ѧ��־ 2005, 31(4) 205-206 DOI: ISSN: 2096-5540 CN: 32-1880/R

��Ŀ¼ | ��Ŀ¼ | �� | �߼�� [��ӡ��ҳ] [�ر�]

��

	��չ��

	��Ϣ
	Supporting info
	PDFȫ��
	[HTMLȫ��]
	�ο��
	��뷴��
	�ѱ��Ƽ��
	��ҵ��
	��ù��
	��ñ��
	Email Alert
	��·��
	��Ϣ
	��Ĺؼ��
	��崯
	��
	��
	��ƽ
	��ȫ��
	PubMed
	Article by
	Article by

��崯��ƽ�չ

��ƽ, ��ȫ��

��ҽ�ƴ�ѧ��ҽԺƤ��, 300052

ժҪ��

��崯�ǽ�Щ��ű��ʶ��һ��ټ��Դ��Լ��,��Լ��й�֮ͬ��,��ѡ��Ƥ�ʼ��ء��Ƽ��󿼷��CD20��¡��塢��Ī˾��ҩ��Ĥ�𺦽�Ϊ��,�Һϲ��Ƕ��,��Ϊ��֡�

�ؼ���� 崯 ��

Abstract:

Keywords:

�ո�� 2004-11-22 �޻�� ��淢��

DOI:

��Ŀ:

ͨѶ��:

��߼��:

�ο��ף�

[1] Vecchietti G, Kerl K, Hugli A,et al. Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus. Br J Dermatol, 2003, 148:833-834.
[2] Heizmann M, Itin P, Wernli M, et al. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. Am J Hematol, 2001, 66:142-144.
[3] Mutasim DF. Autoimmune bullous dermatoses in the elderly: diagnosis and management. Drugs Aging, 2003, 20:663-681.
[4] Dega H, Laporte JL, Joly P, et al. Paraneoplastic pemphigus associated with Hodgkin's disease. Br J Dermatol, 1998, 138:196-198.
[5] Hertzberg MS, Schifter M, Sullivan J, et al. Paraneoplastic pemphigus in two patients with B-cell non-Hodgkin's lymphoma: significant responses to cyclophosphamide and prednisolone. Am J Hematol,2000, 63:105-106.
[6] Becker LR, Bastian BC, Wesselmann U, et al. Paraneoplastic pemphigus treated with dexamethasone/cyclophosphamide pulse therapy.Eur J Dermatol, 1998, 8:551-553.
[7] Krunic AL, Kokai D, Bacetic B, et al. Retroperitoneal round-cell liposarcoma associated with paraneoplastic pemphigus presenting as lichen planus pemphigoides-like eruption. Int J Dermatol, 1997, 36:526-529.
[8] Anhalt GJ. Paraneoplastic pemphigus. Adv Dermatol, 1997, 12:77.
[9] Nousari HC, Brodsky RA, Jones RJ, et al. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease. J Am Acad Dermatol, 1999, 40:750-754.
[10] Williams JV, Marks JG Jr, Billingsley EM. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus. Br J Dermatol,2000, 142:506-508.
[11] Borradori L, Lombardi T, Samson J,et al. Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus. Arch Dermatol, 2001, 137:269-272.
[12] Schoen H, Foedinger D, Derfler K, et al. Immunoapheresis in paraneoplastic pemphigus. Arch Dermatol, 1998, 134:706-710.
[13] Vun YY, Lun K, Strutton G. Use of biosynthetic dressings in paraneoplastic pemphigus. Australas J Dermatol, 2004, 45:133-135.

��е��

1��¥��, ��ɽ�.��崯��ƽ�չ[J]. ��Ƥ��Բ�ѧ��־, 2007,33(6): 331-333

2��,��,��,.��򵰰��Ѱ��崯��Ч�۲�[J]. ��Ƥ��Բ�ѧ��־, 2008,34(4): 215-217

3��,��.��崯[J]. ��Ƥ��Բ�ѧ��־, 2008,34(6): 388-390

4��Ӣ,�ｨ��,.��崯�ķ��ͼ��µ��[J]. ��Ƥ��Բ�ѧ��־, 2009,35(1): 33-35

5�� ۳��.��Ƥ��[J]. ��Ƥ��Բ�ѧ��־, 2009,35(5): 312-314

6��ջݴ� �̲� ʩ�� ۳��.��Դ��Ա�Ƥ�ɽ�֢�鹬��״ϸ��һ��[J]. ��Ƥ��Բ�ѧ��־, 2010,36(2): 66-68

7��ѧ�� Ƽ �Ŵ�.��崯��ƽ̦޺һ��[J]. ��Ƥ��Բ�ѧ��־, 2010,36(2): 114-114

8�� Ӣ Ҷ�ľ�.��ܲ�λ�ļ��崯һ��ϵ[J]. ��Ƥ��Բ�ѧ��־, 2010,36(3): 174-174

9��, ��.��崯��о��չ[J]. ��Ƥ��Բ�ѧ��־, 0,(): 367-369

10��, �Ÿ��.��崯��ѧ�о��½�չ[J]. ��Ƥ��Բ�ѧ��־, 0,(): 370-372

11��Ⱥ��, ��ѧ��У .��崯��ԭ��ӵ��о��չ[J]. ��Ƥ��Բ�ѧ��־, 1994,20(2): 70-72